Literature DB >> 32632526

A systematic review of trends in all-cause mortality among people with diabetes.

Lei Chen1, Rakibul M Islam2, Joanna Wang1, Thomas R Hird1,2, Meda E Pavkov3, Edward W Gregg4, Agus Salim1,5, Maryam Tabesh1, Digsu N Koye1, Jessica L Harding3, Julian W Sacre1, Elizabeth L M Barr1,6, Dianna J Magliano7,8, Jonathan E Shaw1,2,9.   

Abstract

AIMS/HYPOTHESIS: We examined all-cause mortality trends in people with diabetes and compared them with trends among people without diabetes.
METHODS: MEDLINE, EMBASE and CINAHL databases were searched for observational studies published from 1980 to 2019 reporting all-cause mortality rates across ≥2 time periods in people with diabetes. Mortality trends were examined by ethnicity, age and sex within comparable calendar periods.
RESULTS: Of 30,295 abstracts screened, 35 studies were included, providing data on 69 separate ethnic-specific or sex-specific populations with diabetes since 1970. Overall, 43% (3/7), 53% (10/19) and 74% (32/43) of the populations studied had decreasing trends in all-cause mortality rates in people with diabetes in 1970-1989, 1990-1999 and 2000-2016, respectively. In 1990-1999 and 2000-2016, mortality rates declined in 75% (9/12) and 78% (28/36) of predominantly Europid populations, and in 14% (1/7) and 57% (4/7) of non-Europid populations, respectively. In 2000-2016, mortality rates declined in 33% (4/12), 65% (11/17), 88% (7/8) and 76% (16/21) of populations aged <40, 40-54, 55-69 and ≥70 years, respectively. Among the 33 populations with separate mortality data for those with and without diabetes, 60% (6/10) of the populations with diabetes in 1990-1999 and 58% (11/19) in 2000-2016 had an annual reduction in mortality rates that was similar to or greater than in those without diabetes. CONCLUSIONS/
INTERPRETATION: All-cause mortality has declined in the majority of predominantly Europid populations with diabetes since 2000, and the magnitude of annual mortality reduction matched or exceeded that observed in people without diabetes in nearly 60% of populations. Patterns of diabetes mortality remain uncertain in younger age groups and non-Europid populations. REGISTRATION: PROSPERO registration ID CRD42019095974. Graphical abstract.

Entities:  

Keywords:  Diabetes; Epidemiology; Mortality; Systematic review; Trends

Year:  2020        PMID: 32632526     DOI: 10.1007/s00125-020-05199-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

1.  A Journey in Diabetes: From Clinical Physiology to Novel Therapeutics: The 2020 Banting Medal for Scientific Achievement Lecture.

Authors:  Ele Ferrannini
Journal:  Diabetes       Date:  2021-02       Impact factor: 9.461

2.  Type 2 Diabetes Increases Risk of Unfavorable Survival Outcome for Postoperative Ischemic Stroke in Patients Who Underwent Non-cardiac Surgery: A Retrospective Cohort Study.

Authors:  Faqiang Zhang; Yulong Ma; Yao Yu; Miao Sun; Hao Li; Jingsheng Lou; Jiangbei Cao; Yanhong Liu; Mu Niu; Long Wang; Weidong Mi
Journal:  Front Aging Neurosci       Date:  2022-01-11       Impact factor: 5.750

3.  Diabetes free life expectancy and years of life lost associated with type 2 diabetes: projected trends in Germany between 2015 and 2040.

Authors:  Thaddäus Tönnies; Jens Baumert; Christin Heidemann; Elena von der Lippe; Ralph Brinks; Annika Hoyer
Journal:  Popul Health Metr       Date:  2021-10-11

Review 4.  Efficacy and Safety of the Chinese Patent Medicine Yuquan Pill on Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis.

Authors:  Sihan Peng; Ziyan Xie; Xiyu Zhang; Chunguang Xie; Jian Kang; Haipo Yuan; Gang Xu; Xiangeng Zhang; Ya Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-02       Impact factor: 2.629

Review 5.  [Physical and psychological long-term consequences of diabetes mellitus].

Authors:  Bernhard Kulzer
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-03-16       Impact factor: 1.513

6.  High glucose represses the proliferation of tendon fibroblasts by inhibiting autophagy activation in tendon injury.

Authors:  Fu-Chen Song; Jia-Qin Yuan; Mei-Dong Zhu; Qi Li; Sheng-Hua Liu; Lei Zhang; Cheng Zhao
Journal:  Biosci Rep       Date:  2022-03-31       Impact factor: 3.840

7.  Trends in all-cause mortality and major causes of death between 2007 and 2018 among patients with diabetes in Taiwan.

Authors:  Jun-Sing Wang; Yi-Ling Wu; Horng-Yih Ou; Yi-Sun Yang; Chih-Cheng Hsu; Chii-Min Hwu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-09       Impact factor: 6.055

Review 8.  Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease.

Authors:  Hiroaki Yagyu; Hitoshi Shimano
Journal:  J Diabetes Investig       Date:  2022-06-14       Impact factor: 3.681

9.  Trends in type 2 diabetes mellitus disease burden in European Union countries between 1990 and 2019.

Authors:  Richard Goodall; Andrew Alazawi; Will Hughes; Vassiliki Bravis; Justin D Salciccioli; Dominic C Marshall; Conor Crowley; Joseph Shalhoub
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.